What is it?
The A1C test (also called HbA1c, glycated hemoglobin, or glycohemoglobin) is a blood test that measures your average blood sugar (glucose) levels over the past 2-3 months. Unlike daily glucose tests that provide a snapshot, A1C gives a long-term view of blood sugar control. When glucose enters the bloodstream, some of it binds to hemoglobin (the oxygen-carrying protein in red blood cells) in a process called glycation. Since red blood cells live approximately 120 days, the percentage of glycated hemoglobin reflects average glucose exposure over that period. A1C is expressed as a percentage: higher percentages indicate higher average blood glucose levels. This test is crucial for diagnosing prediabetes and diabetes, monitoring diabetes management effectiveness, and predicting risk of diabetes complications.
Formula Details
A1C works through the process of glycation—glucose binds to hemoglobin in red blood cells over their approximately 120-day lifespan. Two main standardization systems exist: NGSP (National Glycohemoglobin Standardization Program), used primarily in the United States, reports A1C as a percentage; IFCC (International Federation of Clinical Chemistry), used internationally, reports in mmol/mol. An NGSP value of 7.0% equals an IFCC value of 53 mmol/mol. The estimated Average Glucose (eAG) is derived from A1C using two equivalent formulas: eAG (mg/dL) = (A1C% × 20.582) − 1.526, or eAG (mmol/L) = (A1C% × 1.194) − 0.0846. This conversion bridges the gap between laboratory A1C results and the daily glucose readings patients see on their blood sugar meters, making long-term trends easier to understand and act upon.
How to Calculate
A1C is measured through a simple blood test that requires no fasting. The test quantifies the percentage of hemoglobin molecules that have glucose attached. The American Diabetes Association formula converts A1C to estimated average glucose (eAG): eAG (mg/dL) = (28.7 × A1C) - 46.7. For example, an A1C of 7% converts to: (28.7 × 7) - 46.7 = 154 mg/dL average glucose. To convert to mmol/L, divide mg/dL by 18.018. A1C levels are categorized: Normal < 5.7%, Prediabetes 5.7-6.4%, Diabetes ≥ 6.5%. For people with diabetes, treatment goals typically aim for A1C < 7% (individualized based on age, complications, and other factors).
Categories
| BMI Range | Category | Description |
|---|---|---|
< 5.7% | Normal | Blood sugar levels are within a healthy range. Maintain healthy lifestyle habits including a balanced diet and regular physical activity to keep A1C in the normal zone. |
5.7% – 6.4% | Pre-diabetes | Blood sugar is higher than normal but not yet at the diabetes threshold. Lifestyle changes—improved diet, regular exercise, and weight management—can often reverse or delay progression to diabetes. |
≥ 6.5% | Diabetes | A1C meets the diagnostic threshold for diabetes. A medical evaluation, personalized treatment plan, and ongoing monitoring with healthcare guidance are essential. |
< 7.0% (Diabetic Target) | Well-Controlled Diabetes | For individuals already managing diabetes, an A1C below 7% indicates good blood sugar control and significantly lower risk of long-term complications. This target is individualized by your doctor. |
Interpretation
Your A1C percentage represents your average blood glucose over the past 2-3 months, making it one of the most reliable indicators of long-term glycemic control. Each 1% increase in A1C corresponds to roughly 25-30 mg/dL higher average blood glucose. The relationship between A1C and complications is well-documented: for every 1% reduction, heart disease risk drops by about 14%, retinopathy risk decreases by 37%, nephropathy risk falls by 33%, and neuropathy risk reduces by 43%. For people without diabetes, the goal is staying below 5.7%. For those managing diabetes, targets are personalized—younger, healthier individuals may aim for below 6.5%, while elderly patients or those with complications may have a relaxed target of 7.5–8% to avoid hypoglycemia. Always discuss your personal A1C target with your healthcare provider.
Limitations
A1C testing has several important limitations. Conditions that alter red blood cell lifespan can skew results: iron deficiency anemia, hemolytic anemias, recent blood transfusions, and bleeding events cause falsely low A1C. Hemoglobin variants such as sickle cell trait interfere with certain testing methods. Kidney disease and liver disease can also affect accuracy. Critically, A1C does not reveal glucose variability—a person may have a 7% A1C with steady levels or with dangerous spikes and drops, both showing the same number. This is why continuous glucose monitoring (CGM) is an increasingly valuable complement. A1C is not recommended for diagnosing diabetes during pregnancy because hormones alter red blood cell turnover. Altitude, certain medications, and even recent intense exercise can influence results. Despite these limitations, A1C remains the most practical test for long-term blood sugar monitoring.
Health Risks
Persistently elevated A1C indicates prolonged high blood sugar, which gradually damages blood vessels and nerves throughout the body. Major complications of uncontrolled diabetes include: cardiovascular disease—heart attack and stroke risk doubles or triples; diabetic retinopathy—damage to retinal blood vessels and the leading cause of blindness in working-age adults; diabetic nephropathy—progressive kidney damage that can progress to end-stage renal disease requiring dialysis or transplant; peripheral neuropathy—nerve damage causing numbness, pain, and loss of sensation starting in the feet; and impaired wound healing that can lead to serious infections and amputations. Even pre-diabetes (A1C 5.7–6.4%) carries elevated cardiovascular risk. The encouraging finding is that these complications are largely preventable: each 1% reduction in A1C decreases overall complication risk by 20–40%, and intervention during pre-diabetes can prevent progression to diabetes by up to 58%.
Alternative Body Composition Measures
Several tests complement or replace A1C depending on the clinical situation. Fasting Plasma Glucose (FPG) measures blood sugar after at least 8 hours without eating—126 mg/dL or above indicates diabetes. The Oral Glucose Tolerance Test (OGTT) measures blood sugar 2 hours after a glucose drink and is the gold standard for diagnosis, required specifically for diagnosing gestational diabetes. Random Blood Glucose can be taken at any time and is useful for screening. Continuous Glucose Monitoring (CGM) systems—such as Dexcom or FreeStyle Libre—use sensors to track glucose every few minutes, revealing variability and patterns A1C cannot show. The "Time in Range" metric (percentage of time glucose stays between 70–180 mg/dL) from CGM is increasingly recognized as more informative than A1C alone. Insulin sensitivity testing (HOMA-IR) evaluates how efficiently the body uses insulin and helps identify insulin resistance.
Demographic Differences
Diabetes risk and A1C interpretation vary across populations. Age is the most significant factor: risk increases sharply after 45, with the highest incidence among adults over 65. A1C targets for older adults are often relaxed (< 8%) because aggressive glucose control raises hypoglycemia risk. Ethnicity plays an important role—African American, Hispanic/Latino, American Indian/Alaska Native, Asian American, and Pacific Islander populations have substantially higher rates of type 2 diabetes. Research indicates that individuals of African descent may register slightly higher A1C at identical glucose levels, potentially affecting screening accuracy. Pregnancy dramatically changes glucose metabolism: gestational diabetes affects 6–9% of pregnancies and must be diagnosed through OGTT, not A1C. Women have a higher lifetime risk of type 2 diabetes, and menopause further increases this risk. Socioeconomic factors—diet quality, physical activity access, and healthcare availability—profoundly influence both risk and management outcomes.
Tips
1Get A1C tested at least twice yearly if meeting treatment goals, quarterly if not
2Combine A1C testing with daily glucose monitoring for comprehensive diabetes management
3A1C reflects average glucose - it won't show dangerous highs or lows that occur briefly
4Even small A1C reductions (0.5-1%) significantly decrease complication risks
5Individualize A1C targets: tighter control (< 6.5%) for some, relaxed (< 8%) for others
6Track your diet, exercise, and medication adherence to identify patterns that affect your A1C
7Pair A1C results with CGM data for the most complete picture of blood sugar management
Frequently Asked Questions
What is a good A1C level?
For people without diabetes, normal A1C is below 5.7%. Prediabetes is 5.7-6.4%, and diabetes is diagnosed at 6.5% or higher. For those with diabetes, the American Diabetes Association recommends a general target of < 7%, but this should be individualized. Younger, healthier patients might aim for < 6.5%, while elderly patients or those with complications might target < 8%. Discuss your personalized A1C goal with your healthcare provider.
How often should I get my A1C tested?
Test frequency depends on your diabetes status and control. For people with diabetes meeting treatment goals: at least twice yearly. For those not meeting goals or changing treatments: every 3 months. For prediabetes screening: annually or as recommended by your doctor. Always follow your healthcare provider's specific recommendations.
How can I lower my A1C?
Lowering A1C requires sustained blood glucose control through: (1) Healthy eating - reduce refined carbohydrates, increase fiber, control portions; (2) Regular exercise - 150 minutes/week of moderate activity improves insulin sensitivity; (3) Weight loss - losing 5-10% of body weight significantly improves A1C; (4) Medication adherence; (5) Stress management and adequate sleep. Small improvements compound - reducing A1C by just 1% decreases heart attack risk by 14%.
What is the difference between A1C and daily blood sugar testing?
A1C provides a 2-3 month average of blood glucose levels, while daily blood sugar tests—whether fingerstick or continuous glucose monitoring—show a moment-in-time snapshot of where your glucose is right now. The key limitation of A1C is that it can mask dangerous highs and lows: two people with the same A1C of 7% may have very different glucose patterns, one steady and one swinging wildly. Both tests serve important but different roles—A1C is best for evaluating long-term trends and guiding treatment decisions, while daily testing or CGM is essential for making real-time decisions about meals, activity, and insulin dosing.
Can I have diabetes with a normal A1C?
Yes—A1C can appear normal in the early stages of diabetes, particularly if you have conditions that alter red blood cell lifespan such as iron deficiency anemia, hemolytic anemias, or recent blood transfusions. In these cases, A1C may underestimate true glucose exposure. Fasting plasma glucose and the oral glucose tolerance test (OGTT) can detect diabetes that A1C misses because they measure glucose directly rather than relying on hemoglobin turnover. A1C is also less reliable during pregnancy, when hormonal changes accelerate red blood cell production and cause falsely low readings. If you have risk factors for diabetes but a normal A1C, ask your doctor whether additional testing is appropriate.
How does A1C compare to fasting blood sugar for diagnosis?
Both A1C and fasting blood sugar (FPG) are accepted diagnostic tests for diabetes. A fasting blood sugar of 126 mg/dL or higher, or an A1C of 6.5% or higher, meets the diagnostic threshold. The oral glucose tolerance test (OGTT)—which measures blood sugar 2 hours after a standardized glucose drink—is considered the gold standard because it most closely mimics real-world carbohydrate loads. If one test gives a borderline result, guidelines recommend repeating it or confirming with a second test type. The preferred diagnostic method depends on the clinical situation: A1C is convenient because it requires no fasting, while OGTT is specifically required for diagnosing gestational diabetes.
What foods have the biggest impact on A1C?
Refined carbohydrates cause the largest and most rapid spikes in blood glucose—these include white bread, white rice, sugary beverages, pastries, and processed snack foods. Foods high in fiber (such as vegetables, legumes, and whole grains), lean proteins, and healthy fats produce slower, more gradual glucose rises and have a smaller overall impact on A1C. Low-glycemic carbohydrates—like sweet potatoes, oats, and most fruits—are better choices than their high-glycemic counterparts. Importantly, portion size matters as much as food type: a large serving of a low-glycemic food can raise blood sugar more than a small serving of a high-glycemic one. Eating regular, balanced meals throughout the day also helps prevent the glucose swings that contribute to a higher A1C over time.
References & Sources
- [1]American Diabetes Association - Standards of Medical Care in Diabetes
- [2]Nathan DM, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478.
- [3]Centers for Disease Control and Prevention - A1C Diagnostic Criteria
- [4]International Diabetes Federation - Global Guidelines for Type 2 Diabetes
These references are provided for educational purposes. Always consult healthcare professionals for medical advice.